Xtl Biopharmaceuticals Ltd (XTLB)

CIK 1023549 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Xtl Biopharmaceuticals Ltd.

Recent SEC filings

FiledFormAccession number
Aug 5, 20266-K0001213900-26-085693
Jul 21, 20266-K0001213900-26-080006
Jun 30, 20266-K0001213900-26-073813
Jun 30, 202620-F0001213900-26-073831
Jun 29, 20266-K0001213900-26-073158
Jun 23, 20266-K0001213900-26-070771
May 22, 20266-K0001213900-26-060565
May 15, 20266-K0001213900-26-057942
May 7, 20266-K0001213900-26-053067
Apr 30, 2026NT 20-F0001213900-26-050305
Apr 29, 20266-K0001213900-26-048875
Mar 23, 202630001213900-26-032911
Mar 23, 202630001213900-26-032909
Mar 20, 20266-K0001213900-26-032348
Mar 10, 20266-K0001213900-26-025691
Feb 27, 20266-K0001213900-26-021691
Feb 24, 20266-K0001213900-26-019877
Feb 23, 20266-K0001213900-26-019324
Feb 17, 20266-K0001213900-26-017282
Jan 28, 20266-K0001213900-26-008572
Jan 23, 20266-K0001213900-26-007213
Jan 23, 20266-K0001213900-26-007212
Jan 13, 20266-K0001213900-26-003911
Jan 13, 20266-K0001213900-26-003672
Dec 30, 20256-K0001213900-25-126514